Cardiology
The Novo Nordisk Foundation is going global on cardiometabolic disease.
One of the world’s largest foundations is directing more funding beyond Denmark and making obesity, diabetes and cardiovascular disease a central international priority. The investment could fill a dangerous gap in global health. It also raises a harder question: when public systems underfund chronic disease, how much influence should private philanthropy have over what gets…
Africa’s Cardiovascular Decade Is a System-Design Problem
Inherited Lipid Screening Becomes Europe’s Prevention Test
ATTR Gene Editing Restarts, But Safety Becomes the Access Question
Routine CT Scans Could Become a Heart Failure Early-Warning System
Risk Prediction Cannot Simply Be Imported From Europe
Personalised Cardiology Needs a Digital Fabric, Not Just More Data
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.